[Translation] A randomized, double-blind, placebo-controlled, multicenter phase IIa clinical trial on the safety and efficacy of Chunkang Xuezhi Capsule in the treatment of primary hyperlipidemia
通过高、中、低不同治疗剂量的探索,初步评价纯康血脂胶囊治疗原发性高脂血症在降低TC、TG、LDL-C,升高HDL-C的方面优于安慰剂的有效剂量。 通过实验室检查、临床症状、体征、不良事件/严重不良事件等,评价纯康血脂胶囊的安全性。
[Translation] Through the exploration of high, medium and low different treatment doses, it was preliminarily evaluated that Chunkang Blood Lipid Capsules were superior to placebo in the treatment of primary hyperlipidemia in terms of reducing TC, TG, LDL-C and increasing HDL-C. The safety of Chunkang Blood Lipid Capsules was evaluated through laboratory tests, clinical symptoms, signs, adverse events/serious adverse events, etc.